Correlation between PLC zeta measurements and semen parameters in male infertility
Official title: Assessing the Correlation Between Phospholipase C Zeta (PLCZeta) Measurements and Semen Parameters
Run by Fakih IVF Fertility Center · NCT07684339 · Data updated 2026-11-12
This study tests whether levels of the sperm protein PLCζ in semen relate to standard semen quality measures in men facing infertility.
Quick facts
| Study type | Observational |
|---|---|
| Sex | Men only |
| Enrollment | 200 (estimated) |
| Sponsor | Fakih IVF Fertility Center Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Abu Dhabi and 1 other locations) |
| Status | Recruiting |
| Started | July 1, 2026 |
| Main results expected | July 1, 2027 |
| Study ends | August 2027 |
| Registry record updated | July 6, 2026 |
| Trial ID | NCT07684339 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are couples seeking fertility treatment who have a total sperm count of at least 1 million per mL and have leftover sperm available after clinical procedures.
✕Probably not a fit
Patients with normal PLCζ function or those whose fertility challenges are unrelated to PLCζ may not experience direct benefit from this observational analysis.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study examines the relationship between phospholipase C zeta (PLCζ) measurements in semen and common semen parameters in men with infertility. Participants are couples pursuing IVF/ICSI or routine semen analysis, with leftover sperm available for testing. No intervention is administered beyond standard clinical care, and treatment outcomes from routine procedures are collected for analysis. The goal is to see if PLCζ levels could explain variability in fertilization potential and embryo development. The study is conducted at Fakih IVF Fertility Center in Abu Dhabi with collaboration from Khalifa University for Science and Technology.
Why it matters
Potential benefit: If PLCζ measurements correlate with semen quality, this could help personalize fertility treatments and identify couples who may benefit from specific activation or assisted techniques.
How similar studies have gone: Previous research has suggested PLCζ plays a role in oocyte activation, but the clinical utility of measuring PLCζ for predicting ART outcomes remains an area of active investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Couple inclusion criteria: * Presenting to the IVF clinic for IVF/ICSI treatment or routine semen analysis * Semen sample must have a total sperm count of ≥1 million sperm/ml * Availability of excess, leftover sperm after clinical treatment procedures * Couples must have experienced infertility for at least one year and be undergoing fertility treatment * Undergoing standard clinical treatment protocols (including embryo culture and, when applicable, PGTA) with routinely collected treatment outcome data * Sufficient ovarian reserve and/or meeting the clinic's standard criteria for fertility treatment Couple exclusion criteria: * Known genetic disorders affecting fertility * History of vasectomy or other irreversible sterilization procedures * Current use of medications known to affect sperm parameters (e.g., exogenous androgens, chemotherapeutic agents, or other drugs specifically impacting spermatogenesis) * Recent history of chemotherapy or radiation therapy * Female age \>38 years old * Known chromosomal abnormalities or genetic disorders that directly affect oocyte quality or embryo development * Presence of severe uterine or pelvic pathology (e.g., significant uterine anomalies, advanced endometriosis) * Documented ovarian failure or extremely diminished ovarian reserve as determined by AMH levels (AMH \>1 ng/mL, AFC ≥5) * Use of medications or undergoing treatments that could significantly alter oocyte quality or embryogenesis (outside standard ART protocols).
Where it's running
-
Fakih IVF
Abu Dhabi, United Arab Emirates Recruiting -
Khalifa University
Abu Dhabi, United Arab Emirates Active not recruiting
Study contacts
- Principal investigator: Junaid Kashir, PhD — Khalifa University
- Study coordinator: Dr. Lamiya Mohiyiddeen, MD, FRCOG
- Email: lamiya.mohiyiddeen@fakihivf.com
- Phone: +971543676002
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Single infrapubic versus bilateral subinguinal microsurgical varicocelectomy for bilateral varicocele
This trial tests whether a single infrapubic approach can fix both varicoceles more quickly and with less pain than the standard two-incision bilateral approach in men with infertility.
-
Live motile sperm sorting device vs standard sperm prep in older men for IVF outcomes
This study tests whether the LensHooke CA0, a centrifugation-free sperm sorting method, improves IVF outcomes for couples where the male partner is 40 or older.
-
AI tool to analyze sperm and predict their ability to help IVF/ICSI succeed
This project will test an AI platform that analyzes semen samples from men providing sperm for IVF/ICSI to see if it can predict which samples have the best chance of supporting successful IVF/ICSI outcomes.
-
Daily gazpacho to improve semen quality in men with reduced sperm parameters
This study will test whether drinking a daily 330 mL serving of gazpacho for 12 weeks helps men with reduced sperm quality improve their semen parameters and lower oxidative stress.
-
Probiotics to improve sperm count, motility, and morphology in men with low sperm quality
This study tests whether daily probiotic supplements can improve sperm count, motility, and morphology in men with unexplained low sperm quality.
-
Royal Jelly to Help Unexplained Male Infertility
A randomized, placebo-controlled study tests whether daily royal jelly can improve sperm DNA integrity and help couples achieve pregnancy when the man’s fertility appears normal by standard tests.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.